Rory L. Smoot
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 70
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 21
- Cancer Research top 2%
- Surgery top 1%
- Cholangiocarcinoma and Gallbladder Cancer Studies 47
- Pancreatitis Pathology and Treatment 19
-
- Gallbladder and Bile Duct Disorders 22
-
- Neuroendocrine Tumor Research Advances 27
- Liver Disease Diagnosis and Treatment 10
-
- Neuroblastoma Research and Treatments 11
- Co-authors
- David M. NagorneyMark J. TrutyMichael L. KendrickMichael B. FarnellGregory J. GoresNathan W. WerneburgSean P. ClearyElizabeth B. Habermann
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- United StatesAustriaCanada
In The Last Decade
Rory L. Smoot
144 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 2.0k
- Hepatology 487
- Cancer Research 674
- Surgery 1.9k
- Pulmonary and Respiratory Medicine 983
Countries citing papers authored by Rory L. Smoot
This map shows the geographic impact of Rory L. Smoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rory L. Smoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rory L. Smoot more than expected).
Fields of papers citing papers by Rory L. Smoot
This network shows the impact of papers produced by Rory L. Smoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rory L. Smoot. The network helps show where Rory L. Smoot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rory L. Smoot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 22 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 1 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 232 | |
| 15 | 2020 | 20 | |
| 16 | 2019 | 34 | |
| 17 | 2018 | 84 | |
| 18 | 2012 | 158 | |
| 19 | 2010 | 43 | |
| 20 | Minnesota general surgeons. Where do they come from? | 2006 | 4 |
About Rory L. Smoot
Rory L. Smoot is a scholar working on Hepatology, Oncology and Surgery, having authored 159 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (70 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (47 papers), Neuroendocrine Tumor Research Advances (27 papers), Gallbladder and Bile Duct Disorders (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Pancreatitis Pathology and Treatment (19 papers), Neuroblastoma Research and Treatments (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (2.0k citations), Hepatology (487 citations) and Cancer Research (674 citations). Rory L. Smoot has collaborated with scholars based in United States, Austria and Canada. Frequent co-authors include David M. Nagorney, Mark J. Truty, Michael L. Kendrick, Michael B. Farnell, Gregory J. Gores, Nathan W. Werneburg, Sean P. Cleary, Elizabeth B. Habermann, Rondell P. Graham and Alphonse E. Sirica. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.